{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:42:15Z","timestamp":1771008135980,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960668"],"award-info":[{"award-number":["81960668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060665"],"award-info":[{"award-number":["82060665"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bcp.2022.115188","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T10:54:03Z","timestamp":1658746443000},"page":"115188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation"],"prefix":"10.1016","volume":"203","author":[{"given":"Liangping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2022.115188_b0005","doi-asserted-by":"crossref","unstructured":"R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal. Cancer statistics, 2021. CA Cancer J. Clin. 71 (2021) 7-33.","DOI":"10.3322\/caac.21654"},{"issue":"5","key":"10.1016\/j.bcp.2022.115188_b0010","first-page":"363","article-title":"CA Cancer","volume":"69","author":"Miller","year":"2019","journal-title":"J. Clin."},{"key":"10.1016\/j.bcp.2022.115188_b0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejca.2020.03.006","article-title":"Systemic treatment of brain metastases in non-small cell lung cancer","volume":"132","author":"Page","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2022.115188_b0020","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nm.3854","article-title":"Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2022.115188_b0025","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2022.115188_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2022.115188_b0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41591-018-0264-7","article-title":"Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer","volume":"25","author":"Shah","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2022.115188_b0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41591-018-0323-0","article-title":"Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions","volume":"25","author":"Teixeira","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2022.115188_b0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41467-021-20907-z","article-title":"Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2022.115188_b0050","doi-asserted-by":"crossref","first-page":"10686","DOI":"10.1158\/0008-5472.CAN-07-1461","article-title":"Human papillomavirus 16\/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation","volume":"67","author":"Cheng","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2022.115188_b0055","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1158\/1078-0432.CCR-10-2316","article-title":"Reduced p21(WAF1\/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer","volume":"17","author":"Wu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2022.115188_b0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/carcin\/bgz087","article-title":"The lung-enriched p53 mutants V157F and R158L\/P regulate a gain of function transcriptome in lung cancer","volume":"41","author":"Barta","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2022.115188_b0065","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/s41467-020-15608-y","article-title":"Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation","volume":"11","author":"Kong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2022.115188_b0070","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/jm400487c","article-title":"Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development","volume":"56","author":"Ding","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115188_b0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","article-title":"Effect of the MDM2 antagonist RG7112 on the p53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study","volume":"13","author":"Ray-Coquard","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2022.115188_b0080","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1078-0432.CCR-15-0481","article-title":"Results of the phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia","volume":"22","author":"Andreeff","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2022.115188_b0085","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nature09526","article-title":"Selective activation of p53-mediated tumour suppression in high-grade tumours","volume":"468","author":"Junttila","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2022.115188_b0090","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2017.03.013","article-title":"Reviving the guardian of the genome: small molecule activators of p53","volume":"178","author":"Nguyen","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2022.115188_b0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jmcb\/mjz006","article-title":"Small molecule activators of the p53 response","volume":"11","author":"Ladds","year":"2019","journal-title":"J. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.bcp.2022.115188_b0100","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1074\/jbc.M115.669978","article-title":"A novel naphthalimide compound restores p53 function in non-small cell lung cancer by reorganizing the Bak\u00b7Bcl-xl complex and triggering transcriptional regulation","volume":"291","author":"Zhang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115188_b0105","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1021\/acs.jmedchem.6b01769","article-title":"Phthalazino [1,2-b] quinazolinones as p53 activators: cell cycle arrest, apoptotic response and Bak-Bcl-xl complex reorganization in bladder cancer cells","volume":"60","author":"Zhang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115188_b0110","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1038\/ncomms6059","article-title":"ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2022.115188_b0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s000180050273","article-title":"Functions of the MDM2 oncoprotein","volume":"55","author":"Freedman","year":"1999","journal-title":"Cell Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2022.115188_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03402141","article-title":"MDM2: the ups and downs","volume":"5","author":"Juven-Gershon","year":"1999","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2022.115188_b0125","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1101\/gad.7.7a.1126","article-title":"The p53-MDM2 autoregulatory feedback loop","volume":"7","author":"Wu","year":"1993","journal-title":"Genes. Dev."},{"key":"10.1016\/j.bcp.2022.115188_b0130","doi-asserted-by":"crossref","first-page":"19251","DOI":"10.1074\/jbc.C200150200","article-title":"Mutual dependence of MDM2 and MDMX in their functional inactivation of p53","volume":"277","author":"Gu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115188_b0135","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/MCB.23.15.5113-5121.2003","article-title":"MDM2 promotes ubiquitination and degradation of MDMX","volume":"23","author":"Pan","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2022.115188_b0140","doi-asserted-by":"crossref","unstructured":"J.P. Kruse, W. Gu. SnapShot: p53 posttranslational modifications. Cell 133 (2008) 930-30. e1.","DOI":"10.1016\/j.cell.2008.05.020"},{"key":"10.1016\/j.bcp.2022.115188_b0145","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","article-title":"Activation of the ATM kinase by ionizing radiation and phosphorylation of p53","volume":"281","author":"Canman","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2022.115188_b0150","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1093\/emboj\/18.24.7002","article-title":"Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2","volume":"18","author":"Dumaz","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2022.115188_b0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2022.115188_b0160","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1101\/gad.886901","article-title":"ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage","volume":"15","author":"Maya","year":"2001","journal-title":"Genes. Dev."},{"key":"10.1016\/j.bcp.2022.115188_b0165","first-page":"227","article-title":"Signaling to p53: breaking the posttranslational modification code","volume":"48","author":"Appella","year":"2000","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.bcp.2022.115188_b0170","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/sj.onc.1202620","article-title":"The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro","volume":"18","author":"Cuddihy","year":"1999","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2022.115188_b0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1097-2765(01)00176-9","article-title":"A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1","volume":"7","author":"Keller","year":"2001","journal-title":"Mol. Cell"},{"issue":"1-2","key":"10.1016\/j.bcp.2022.115188_b0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-011-0966-3","article-title":"Induction and activation of the p53 pathway: a role for the protein kinase CK2?","volume":"356","author":"Meek","year":"2011","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.bcp.2022.115188_b0185","doi-asserted-by":"crossref","first-page":"29380","DOI":"10.1074\/jbc.271.46.29380","article-title":"Mutation of phosphoserine 389 affects p53 function in vivo","volume":"271","author":"Hao","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115188_b0190","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1158\/0008-5472.CAN-04-4328","article-title":"Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas","volume":"65","author":"Hoogervorst","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2022.115188_b0195","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/MCB.01610-07","article-title":"The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts","volume":"28","author":"Bruins","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115188_b0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes","volume":"9","author":"Riley","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2022.115188_b0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2022.115188_b0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1684\/ecn.2011.0270","article-title":"Epidermal growth factor receptor (EGFR) abundance correlates with p53 and Bcl-2 accumulation and patient age in a small cohort of North African nasopharyngeal carcinoma patients","volume":"22","author":"Bourouba","year":"2011","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcp.2022.115188_b0215","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/JTO.0b013e3181dd15c0","article-title":"Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung","volume":"5","author":"Yoo","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2022.115188_b0220","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1021\/jm070315q","article-title":"2,2,2-Trichloro-N-({2-[2-(dimethylamino) ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}carbamoyl) acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity","volume":"50","author":"Van Quaquebeke","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115188_b0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.10.043","article-title":"A global map of p53 transcription-factor binding sites in the human genome","volume":"124","author":"Wei","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2022.115188_b0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cbi.2015.08.009","article-title":"Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents","volume":"240","author":"Joshi","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2022.115188_b0235","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10495-014-1035-7","article-title":"The p53 control of apoptosis and proliferation: lessons from Drosophila","volume":"19","author":"Mollereau","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2022.115188_b0240","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00709-013-0548-1","article-title":"p53 protein in proliferation, repair and apoptosis of cells","volume":"251","author":"Wawryk-Gawda","year":"2014","journal-title":"Protoplasma"},{"key":"10.1016\/j.bcp.2022.115188_b0245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.abb.2014.05.029","article-title":"ATM-p53 pathway causes G2\/M arrest, but represses apoptosis in pseudolaric acid B-treated HeLa cells","volume":"558","author":"Yao","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2022.115188_b0250","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2022.115188_b0255","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2022.115188_b0260","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1128\/MCB.24.15.6728-6741.2004","article-title":"In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation","volume":"24","author":"Erster","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2022.115188_b0265","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1172\/JCI32481","article-title":"CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice","volume":"117","author":"Tang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2022.115188_b0270","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjc.2015.85","article-title":"Mitochondrial apoptosis: killing cancer using the enemy within","volume":"112","author":"Lopez","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2022.115188_b0275","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1021\/acsami.7b14548","article-title":"Aggregation-induced fluorescence probe for monitoring membrane potential changes in mitochondria","volume":"10","author":"Li","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bcp.2022.115188_b0280","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Kroemer","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2022.115188_b0285","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","article-title":"Cytochrome C-mediated apoptosis","volume":"73","author":"Jiang","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2022.115188_b0290","first-page":"133","article-title":"Palbociclib triggers apoptosis in bladder cancer cells by Cdk2-induced Rad9-mediated reorganization of the Bak","volume":"163","author":"Zhang","year":"2019","journal-title":"Bcl-xl complex. Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115188_b0295","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bbamcr.2010.12.019","article-title":"Molecular biology of Bax and Bak activation and action","volume":"1813","author":"Westphal","year":"2011","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.bcp.2022.115188_b0300","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07986","article-title":"Cytoplasmic functions of the tumour suppressor p53","volume":"458","author":"Green","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2022.115188_b0305","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2012.05.014","article-title":"p53 opens the mitochondrial permeability transition pore to trigger necrosis","volume":"149","author":"Vaseva","year":"2012","journal-title":"Cell"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222002829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222002829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:14:51Z","timestamp":1762096491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222002829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":61,"alternative-id":["S0006295222002829"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115188","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115188"}}